ijms-logo

Journal Browser

Journal Browser

Molecular Mechanism and Pathway in Residual Cardiovascular Risk

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Biology".

Deadline for manuscript submissions: closed (31 August 2021) | Viewed by 445

Special Issue Editor


E-Mail Website
Guest Editor
1. Director, CAU Thrombosis and Biomarker Center, Chung-Ang University Gwangmyeong Hospital, 110, Deokan-ro, Gwangmyeong-si, Gyeonggi-do 14353, Korea
2. Professor, Department of Internal Medicine, Chung-Ang University School of Medicine, Seoul, Korea
Interests: thrombogenicity; glucose; platelet; coagulation; inflammation; East Asian paradox

Special Issue Information

Dear Colleagues,

Despite contemporary evidence-based pharmacologic treatments and interventional strategies, clinical events derived from atherosclerotic cardiovascular disease (ASCVD) remain substantially frequent. Studies have focused on controlling the molecules and pathways related to residual CV risks. In addition, the phenotypes of residual CV risks have become more important than before, since therapeutic strategies for controlling these risks are emerging, and several pharmacologic candidates could reduce the risk of CV events. However, there are unmet needs to develop reliable clinical biomarkers (based on molecular mechanisms and pathways) for targeting the right patients with the right therapies at the right time. Therefore, this Special Issue of the International Journal of Molecular Science will cover various emerging targets and important aspects of residual CV risks, which may contribute to the improvement of patient care.

Dr. Young-Hoon Jeong
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Inflammatory pathway: inflammasomes, adipose tissue, and macrophages/monocytes
  • Clonal hematopoiesis
  • Crosstalk between inflammation and coagulation
  • Platelet biology
  • Coagulation pathway
  • Fibrinolytic pathway
  • Lipid risks: cholesterol, triglycerides, and Lp(a)
  • Glucagon-like peptide-1 (GLP-1) receptor
  • Sodium glucose co-transporter-2 (SGLT-2)

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop